It is known that parvovirus B19 (B19) is transmitted to hemophiliacs by clotting factors prepared from human plasma. However, it is not clear whether B19 is also transmitted by the more recently used inactivated clotting factor preparations. Therefore, we investigated 69 hemophiliacs, mostly children, receiving only virus-inactivated clotting factors. 49 of them (71%) were B19 IgG-positive and 18 of the IgG-positive hemophiliacs (37%) were also B19 IgM-positive. In contrast, out of 73 age-matched controls only 10 (14%) were IgG-positive, two of them being also IgM-positive. In hemophiliacs treated before 1984 with noninactivated clotting factors, seroprevalence was very similar: 94/136 (69%) presented B19 IgG antibodies as compared to their age-matched controls with 16/50 (32%). Out of the 94 IgG-positive patients 24 (26%) were IgM-positive, whereas IgM antibodies were never found in 16 sera of 16 IgG-positive controls. In 4 out of 24 IgM positive hemophiliacs, B19 DNA was detected in the sera by using the polymerase chain reaction. However, B19 DNA was also found in 3/69 anti-B19 IgM-negative, HIV-infected hemophiliacs (all three patients in CDC stage IV). Since it seems unlikely that the results only represent passive acquisition of B19 DNA from blood products and induction of antibodies by immunization with inactivated antigen, the observations rather suggest that infection with B19 is transmitted by clotting factors, including those treated for virus inactivation.
References
1
Craske J,
Kirk P,
Cohen B,
Vandervelde EM.
Commercial factor VIII associated hepatitis, 1974-75, in the United Kingdom: a retrospective survey. JHyg Camb 1978; 80: 327-336
2
Ludlam CA,
Steel CM,
Cheingsong-Popov R,
McClelland DBL,
Tucker J,
Tedder RS,
Weiss RA,
Philp I,
Prescott RJ.
Human T-lymphotropic virus type III (HTLV III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet 1985; 11: 233-236
4
Frickhofen N,
Young NS.
A rapid method of sample preparation for detection of DNA viruses in human serum by polymerase chain reaction. J Virol Methods 1991; 35: 65-72
4
Bailly E,
Kleim JP,
Schneweis KE,
Van Loo B,
Hammerstein U,
Brack-mann HH.
tiAbsence of human immunodeficiency virus (HIV) proviral sequences in seronegative hemophilic men and sexual partners of HIV-seropositive hemophiliacs. Transfusion 1991; 32: 104-108
9
Bartolomei Corsi O,
Azzi A,
Morfini M,
Fanci R,
Rossi Ferrini P.
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988; 25: 165-170
10
Rollag H,
Patou G,
Pattison JR,
Degre M,
Evensen SA,
Froland SS,
Glom-stein A.
Prevalence of antibodies against parvovirus B19 in Norwegians
with congenital coagulation factor defects treated with plasma products from small donor pools. Scand J Infect Dis 1991; 23: 675-679
12
Morfini M,
Longo G,
Rossi Ferrini P,
Azzi A,
Zakrewska C,
Ciappi S,
Kolumban P.
Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: The role of human B19 parvovirus. Am J Hematol 1992; 39: 149-150
14
McOmish F,
Yap PL,
Jordan A,
Hart H,
Cohen BJ,
Simmonds P.
Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. J Clin Microbiol 1993; 31: 323-328
15
Zakrzewska K,
Azzi A,
Patou G,
Morfini M,
Rafanelli D,
Pattison JR.
Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction. Br J Haematol 1992; 81: 407-412
17
Schwarz TF,
Roggendorf M,
Hottentrager B,
Stolz W,
Schwinn H.
Removal of parvovirus B19 from contaminated factor VIII during fractionation. J Med Virol 1991; 35: 28-31
18
Azzi A,
Ciappi S,
Zakvrzewska K,
Morfini M,
Mariani G,
Mannucci PM.
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. Am J Hematol 1992; 39: 228-230
20
Williams MD,
Cohen BJ,
Beddall AC,
Pasi KJ,
Mortimer PP,
Hill FGH.
Transmission of human parvovirus B19 by coagulation factor concentrates. Vox Sang 1990; 58: 177-181
21
Musiani M,
Azzi A,
Zerbini M,
Gibellini D,
Venturoli S,
Zakrzewska K,
Re MC,
Gentilomi G,
Gallinella G,
La Placa M.
Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients. J Med Virol 1993; 40: 157-160
23
Erdman DD,
Usher MJ,
Tsou C,
Caul EO,
Gary GW,
Kajigaya S,
Young NS,
Anderson LJ.
Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectio-sum. J Med Virol 1991; 35: 110-115
24
Torok TJ,
Wang Q-Y,
Gary jr GW,
Yang C-F,
Finch TM,
Anderson LJ.
Prenatal diagnosis of intrauterine infection with parvovirus B19 by polymerase chain reaction technique. Clin Infect Dis 1992; 14: 149-155
